Carcinoma of Unknown Primary
📧 Sign up to get email alerts when something new happens for Carcinoma of Unknown Primary.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer
This clinical trial update describes the use of blood tests and questionnaires to study adherence to preventative swallowing exercises in pa…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction [Phase 1]
Phase 1 trial evaluating veliparib, paclitaxel, and carboplatin in patients with various metastatic or unresectable solid tumors and liver o…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Cancer Genetic Testing in Ethnic Populations [NA]
A Mayo Clinic-sponsored clinical trial update on cancer genetic testing across multiple cancer types in diverse ethnic populations; the stud…
-
CLINICAL_TRIALS research · 2025-01-31Clinical Trial Update: Genomic Investigation of Unusual Responders
This clinical trial update describes a University Health Network study investigating genomic factors in unusual responders across multiple c…
-
CLINICAL_TRIALS research · 2015-10-28Clinical Trial Update: Phase 2 Study of Gemcitabine and Docetaxel Combination Chemotherapy in Patients With Carcinoma of Unknown Primary [Phase 2]
Phase 2 study evaluating gemcitabine and docetaxel chemotherapy in patients with carcinoma of unknown primary.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2013-08-07Clinical Trial Update: Chemotherapy in Treating Patients With Cancer of Unknown Primary Origin [Phase 3]
A Phase 3 clinical trial update about using chemotherapy to treat patients with carcinoma of unknown primary.